Eldepryl

Eldepryl is a brand name of selegiline, approved by the FDA in the following formulation(s):

ELDEPRYL (selegiline hydrochloride - capsule; oral)

• 
  Manufacturer: SOMERSET
  
  Approval date: May 15, 1996
  
  Strength(s): 5MG ^[RLD][AB]

Has a generic version of Eldepryl been approved?

Yes. The following products are equivalent to Eldepryl:

selegiline hydrochloride capsule; oral

• 
  Manufacturer: APOTEX
  
  Approval date: December 4, 1998
  
  Strength(s): 5MG ^[AB]


• 
  Manufacturer: DAVA PHARMS INC
  
  Approval date: November 30, 1998
  
  Strength(s): 5MG ^[AB]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Eldepryl. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

There are no current U.S. patents associated with Eldepryl.

See also...

• Eldepryl Consumer Information (Drugs.com)
• Eldepryl Consumer Information (Wolters Kluwer)
• Eldepryl Consumer Information (Cerner Multum)
• Eldepryl Advanced Consumer Information (Micromedex)
• Eldepryl AHFS DI Monographs (ASHP)
• Selegiline Consumer Information (Wolters Kluwer)
• Selegiline Orally Disintegrating Tablets Consumer Information (Wolters Kluwer)
• Selegiline System Consumer Information (Wolters Kluwer)
• Selegiline Consumer Information (Cerner Multum)
• Selegiline transdermal Consumer Information (Cerner Multum)
• Selegiline Advanced Consumer Information (Micromedex)
• Selegiline Transdermal Advanced Consumer Information (Micromedex)
• Selegiline Hydrochloride AHFS DI Monographs (ASHP)